Silk Road Medical Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Silk Road Medical Inc. (SILK) Tops Q2 EPS by 5c
July 29, 2021 4:41 PM EDTSilk Road Medical Inc. (NASDAQ: SILK) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.34 million.
GUIDANCE:
Silk Road Medical Inc. sees Q3 2021 revenue of $104-109... More
